找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Lung Cancer; New Understandings a Anne C. Chiang,Roy S. Herbst Book 2021 Springer Nature Switzerland AG 2021 lung cancer.NSCLC.SCLC.lung ca

[復(fù)制鏈接]
樓主: 海市蜃樓
31#
發(fā)表于 2025-3-27 00:11:18 | 只看該作者
32#
發(fā)表于 2025-3-27 04:19:19 | 只看該作者
Immunotherapy and Radiotherapy: New Strategies, its application has the potential to liberate tumor antigen in the context of pro-inflammatory cell death. This chapter describes interactions between radiotherapy and the immune system, with a particular focus on an emerging mechanistic understanding of how radiation can materially contribute to an anti-tumor immune response.
33#
發(fā)表于 2025-3-27 05:35:22 | 只看該作者
2199-2584 so include incorporating biomarker data obtained from solid and liquid biopsies, as well as combination of immunotherapy with radiotherapy and in special populations such patients with CNS involvement..978-3-030-74030-6978-3-030-74028-3Series ISSN 2199-2584 Series E-ISSN 2199-2592
34#
發(fā)表于 2025-3-27 10:03:04 | 只看該作者
35#
發(fā)表于 2025-3-27 13:36:56 | 只看該作者
Immune Therapy: What Can We Learn From Acquired Resistance?, defects in IFN- γ signaling, upregulation of alternative immune checkpoint pathways, and various tumor genomic or epigenetic changes have been implicated. In this review, we propose clinical criteria, highlight emerging management strategies, and discuss mechanistic insights into acquired resistance to PD-1 axis inhibitors in NSCLC.
36#
發(fā)表于 2025-3-27 18:03:11 | 只看該作者
37#
發(fā)表于 2025-3-27 23:25:24 | 只看該作者
38#
發(fā)表于 2025-3-28 05:53:48 | 只看該作者
Small Cell Lung Cancer: Biology Advances,al regulators. These analyses are leading to a better understanding of SCLC biology and may help identify distinct therapeutic vulnerabilities among subsets of this disease. Ideally, these investigations will lead to more personalized therapeutic approaches and better outcomes for patients diagnosed with this aggressive cancer.
39#
發(fā)表于 2025-3-28 07:42:43 | 只看該作者
2199-2584 gy to inform clinical management in patients treated with im.Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach.? For targeted and immunotherapeutic approaches, un
40#
發(fā)表于 2025-3-28 13:55:06 | 只看該作者
aser systems are and follow-up data. A detailed description of available to the clinician and the researcher, laser recanalization techniques is presented for which often makes the choice of a laser system the various systems in the clinical setting.978-1-4612-8801-5978-1-4613-1489-9Series ISSN 0166-9842
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 19:49
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
唐山市| 平山县| 自贡市| 湘潭县| 慈溪市| 崇阳县| 海盐县| 阿克陶县| 山东省| 屏山县| 温州市| 花莲县| 临海市| 阿拉善左旗| 舞钢市| 兴宁市| 兰坪| 余姚市| 牟定县| 阿鲁科尔沁旗| 靖西县| 景德镇市| 阿拉善右旗| 静安区| 平塘县| 德州市| 绵阳市| 筠连县| 喀喇沁旗| 曲水县| 文登市| 定兴县| 城固县| 德格县| 峨眉山市| 林州市| 隆林| 阜南县| 资溪县| 环江| 通海县|